MESSANA, VINCENZO GIANLUCA
MESSANA, VINCENZO GIANLUCA
SCIENZE MEDICHE
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome
2024-01-01 Messana V.G.; Fasci A.; Vitale N.; Micillo M.; Rovere M.; Pesce N.A.; Martines C.; Efremov D.G.; Vaisitti T.; Deaglio S.
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors
2019-01-01 Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
2019-01-01 Audrito V.; Manago A.; Gaudino F.; Sorci L.; Messana V.G.; Raffaelli N.; Deaglio S.
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation
2020-01-01 Audrito V.; Messana V.G.; Deaglio S.
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma
2020-01-01 Audrito V.; Messana V.G.; Moiso E.; Vitale N.; Arruga F.; Brandimarte L.; Gaudino F.; Pellegrino E.; Vaisitti T.; Riganti C.; Piva R.; Deaglio S.
Simultaneous inhibition of the B-cell receptor signalling pathway and NAMPT enzyme activity shows potent antitumour activity in xenografts derived from patients with Richter syndrome
2022-12-13
The Extracellular NADome Modulates Immune Responses
2021-01-01 Valentina Audrito; Vincenzo Gianluca; Messana, Lorenzo; Brandimarte ; Silvia Deaglio
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties
2022-01-01 Audrito V.; Moiso E.; Ugolini F.; Messana V.G.; Brandimarte L.; Manfredonia I.; Bianchi S.; De Logu F.; Nassini R.; Szumera-Cieckiewicz A.; Taverna D.; Massi D.; Deaglio S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome | 2024 | Messana V.G.; Fasci A.; Vitale N.; Micillo M.; Rovere M.; Pesce N.A.; Martines C.; Efremov D.G.; Vaisitti T.; Deaglio S. | |
| BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors | 2019 | Valentina Audrito, Antonella Managò, Federica Gaudino, Ilaria Manfredonia, Vincenzo Gianluca Messana, Nicoletta Vitale, Lorenzo Brandimarte, Enrico Moiso, Roberto Piva, Nadia Raffaelli, Mario Mandalà, Silvia Deaglio | |
| NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer | 2019 | Audrito V.; Manago A.; Gaudino F.; Sorci L.; Messana V.G.; Raffaelli N.; Deaglio S. | |
| NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation | 2020 | Audrito V.; Messana V.G.; Deaglio S. | |
| Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma | 2020 | Audrito V.; Messana V.G.; Moiso E.; Vitale N.; Arruga F.; Brandimarte L.; Gaudino F.; Pellegrino E.; Vaisitti T.; Riganti C.; Piva R.; Deaglio S. | |
| Simultaneous inhibition of the B-cell receptor signalling pathway and NAMPT enzyme activity shows potent antitumour activity in xenografts derived from patients with Richter syndrome | 2022 | - | |
| The Extracellular NADome Modulates Immune Responses | 2021 | Valentina Audrito; Vincenzo Gianluca; Messana, Lorenzo; Brandimarte ; Silvia Deaglio | |
| Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties | 2022 | Audrito V.; Moiso E.; Ugolini F.; Messana V.G.; Brandimarte L.; Manfredonia I.; Bianchi S.; De Logu F.; Nassini R.; Szumera-Cieckiewicz A.; Taverna D.; Massi D.; Deaglio S. |